... treatment of hypertension with a com- bination of a direct-acting vasodilator (eg, hydralazine) and a P-adrenoceptor antagonist (eg, propran~lol)~ prompted our studies aimed at designing single chemical entities possessing ... 251-266. Journal of Medicinal Chemistry, 1988, Vol ...